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Hydrogen Isotope Exchange with Highly Active 
Iridium(I) NHC/Phosphine Complexes: a 
Comparative Counter-ion Study 
 
William J. Kerr,a* Richard J. Mudd,a Philippa K. Owens,a Marc Reid,a Jack A. 
Brown,b and Sebastien Camposb 
 
Herein we present a range of substrates that undergo hydrogen isotope exchange 
with an iridium(I) NHC/phosphine complex bearing the less coordinating tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate counterion, and compare these with labelling using 
the equivalent, more established hexafluorophosphate complex. The changes in 
reactivity and selectivity of these complexes in a series of solvents are examined. 
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Introduction 
 
The exchange of hydrogen in a C-H bond 
by deuterium or tritium, through the 
process of hydrogen isotope exchange 
(HIE), represents a direct and economical 
method of generating isotopically-labelled 
molecules.1 Furthermore, due to the 
growing demand for deuterium- and 
tritium-labelled compounds for use in 
determining the pharmacokinetics of 
active pharmaceutical ingredients and in 
mechanistic studies, there has been 
increased focus on the development of 
catalysts capable of facilitating HIE in a 
mild and efficient manner.2 Although a 
wide variety of metals can catalyse the 
HIE process, iridium complexes are the 
most widely utilised for directing-group 
assisted ortho-HIE (Scheme 1).3 
 Historically, this iridium-catalysed, 
directed HIE process has been commonly 
 
 
Scheme 1. Iridium-catalysed ortho-HIE. 
 
SHUIRUPHG XVLQJ &UDEWUHH¶V FDWDO\VW4 
However, the necessity for a high, and, 
indeed, often stoichiometric, catalyst 
loading, has led to attention being turned 
to the use of alternative catalyst species in 
recent years. In this regard, studies within 
our laboratory have delivered a series of 
iridium(I) complexes which are highly 
effective HIE catlaysts,5 and which have 
proven applicable with a wider array of 
functional groups and reaction solvents 
WKDQ &UDEWUHH¶V Fatalyst.6 A key 
breakthrough in this latter regard was the 
synthesis of cationic NHC/phosphine 
complexes bearing alternative counterions 
to the traditional hexafluorophosphate 
(e.g. complex 3). Specifically, improved 
catalyst activity and more general solvent 
applicability was observed with Ir(I) 
NHC/phosphine complex 4, containing the  
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Scheme 2. Ir(I)-NHC/phosphine 
complexes for HIE. 
BArF (tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate) 
counterion (Scheme 2).6b Herein, we 
further expand upon this initial application 
of catalyst 4, and extend the comparison 
of the PF6 and BArF counterions, with 
particular attention to the selectivity within 
the HIE processes reported. 
 
Experimental 
 
For full details on all experimental 
procedures, including catalyst syntheses 
and HIE processes, see the Supporting 
Information. 
 
Results & Discussion 
 
Our studies commenced with a 
comparison of our commercially-available 
catalyst 3, bearing the PF6 counterion, 
with the equivalent catalyst 4, bearing the 
bulky, less coordinating BArF unit. The 
labelling of a range of substrates, featuring 
a variety of different directing groups (DG), 
was evaluated with low loadings of 
catalysts 3 and 4 (Figure 1). From our 
previous work, we had observed that both 
complexes performed excellently with a 
simple ketone directing group (substrate 
5).6b Pleasingly, upon extending these 
studies to the weaker ester DG in 6, high 
levels of deuterium incorporation were, 
again, observed with both catalysts. The 
amide DG in compound 7 delivered similar 
levels of HIE with both complexes 3 and 4. 
Importantly, nitrobenzene 8, which is 
NQRZQQRWWRXQGHUJR+,(ZLWK&UDEWUHH¶V 
catalyst,4b performed excellently with both 
 
Figure 1. ortho-HIE with a series of 
directing groups.a,b,c 
complexes, giving near quantitative 
incorporation with catalyst 4. 
 We have previously reported on the 
utility of complexes 3 and 4 in a range of 
solvents.6a,b During these studies, in a 
single example of a substrate containing 
two competing DGs, a solvent-dependent 
variation in the selectivity of labelling was 
observed. To further develop and 
understand this behaviour, a number of 
multi-functional aromatic compounds were 
selected for study, based upon our earlier 
substrate scope. Firstly, we applied 4-
nitroacetophenone 9 under our previously 
utilised conditions with complexes 3 and 4, 
in DCM, THF, and toluene (Figure 2). In 
DCM, both complexes performed similarly, 
with excellent levels of deuterium 
incorporation observed ortho to the ketone 
DG, and low levels observed ortho- to the 
nitro unit. Lower overall incorporation was 
observed in THF following the same 
regioselectivity trend. Complex 4 also 
delivered the same general ratio of 
labelling in toluene. However, a change in 
selectivity was observed in this solvent  
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Figure 2. HIE on bifunctional substrates 9 
and 10. 
with catalyst 3. Specifically, enhanced 
levels of labelling were now observed 
adjacent to the nitro DG, indicating that, 
with the combination of a less coordinating 
solvent, and the less electrophilic catalyst 
3, both directing groups bind effectively, 
resulting in exchange at both sites. 
 Ethyl 4-nitrobenzoate 10 was next 
examined under the same protocol. In 
accordance with our earlier substrate 
scope study, elevated levels of deuterium 
incorporation were observed with complex 
4 in DCM, with a slight preference for HIE 
ortho to the nitro DG with both catalysts. 
Notably, using THF as the solvent 
significantly reduced HIE at both positions, 
presumably due to solvent vs substrate 
competitive binding with these more 
weakly coordinating DGs.6a,b In toluene, a 
low incorporation was observed with 
complex 3; however, complex 4 proved 
more effective in this case, delivering 
moderate levels of HIE. 
 Next, we examined diethyl 4-
nitrobenzamide 11 under the same 
reaction conditions. High levels of 
incorporation were observed at both 
positions, with complex 3 delivering a 
slightly increased deuterium incorporation 
compared to 4 (Figure 3). However, upon 
changing the solvent to THF, the 
selectivity for HIE ortho to the amide DG  
Figure 3. HIE on bifunctional substrates 
11 and 12. 
was significantly increased with both 3 and 
4. In toluene, moderate to good levels of 
deuterium incorporation were observed, 
with lowered selectivity relative to THF. 
 Finally, we applied this developed 
understanding to labelling of the 
antiandrogen drug, Nilutamide 12. With 
complex 3 in DCM, complete labelling 
ortho to the nitro DG, via a 5-membered 
metallacyclic intermediate (5-mmi) was 
observed, in addition to a small amount of 
labelling directed by the amide through a 
6-mmi. Pleasingly, the use of complex 4 
suppressed this latter pathway, resulting in 
almost exclusive labelling ortho to the nitro 
DG. However, with THF as the solvent, 
the level of incorporation was negligible in 
all positions, in accordance with earlier 
observations that THF binds preferentially 
to the catalyst in place of weakly-directing 
substrates. In toluene, very low levels of 
labelling were observed; however, this is 
mainly attributed to the poor solubility of 
12 in this solvent. 
 
Conclusions 
 
The studies reported herein have provided 
further evidence that complex 4, bearing 
the less coordinating BArF counterion, is 
more reactive than catalyst 3 with less 
J. Labelled Compd. Radiopharm., 2016  W. J. Kerr et al. 
 
J. Labelled Compd. Radiopharm., 2016  W. J. Kerr et al. 
 
coordinating directing groups, but that the 
combination of counterion and solvent is 
vital in delivering a site-selective HIE 
process. In conclusion, both catalysts 3 
and 4 show excellent reactivity, with the 
specific choice of catalyst and solvent 
dependent upon the substrate in question 
and the required position of isotope 
incorporation. 
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